The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
2811 VAXCEL HEPARIN SODIUM INJECTION 5000 IU/ML HEPARIN SODIUM 25.000 IU/5 ML SOLUTION FOR INJECTION VIAL PROPHYLAXIS AND TREATMENT OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM. TREATMENT OF MYOCARDIAL INFARCTION AND ARTERIAL EMBOLISM. NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD KOTRA PHARMA (M) SDN BHD MALAYSIA STEP 1: RECEIVE (RENEW) 12 I 4128/15 03-AUG-2022 02-AUG-2025 View
2812 AMLOMAKS 5 AMLODIPINE BESILATE BP EQ.TO AMLODIPINE 5 MG TABLET ALU-PVC BLISTER HYPERTENSION, CHRONIC STABLE ANGINA PECTORIS, VASOSPASTIC (PRINZMENTAL'S) ANGINA. NULL VIMPEX (LAO) CO.,LTD S KANT HEALTHCARE LTD INDIA CERTIFICATE RELEASED 04 I 5940/24 2024-04-26 2027-04-25 View
2813 ATCAM 8 MG TABLET LORNOXICAM 8 MG FILM COATED TABLET ALU-ALU BLISTER FOR THE TREATMENT OF ACUTE MILD TO MODERATE PAIN, AS WELL AS PAIN AND INFLAMMATION OF THE JOINTS CAUSED BY CERTAIN TYPES OF RHEUMATIC DISEASES. NULL VIMPEX (LAO) CO.,LTD ATCO LABORATORIES LIMITED PAKISTAN CERTIFICATE RELEASED 12 I 5352/22 30-DEC-2022 29-DEC-2025 View
2814 ATRIZIN TABLETS CETIRIZINE HYDROCHLORIDE BP 10 MG TABLET ALU-PVC STRIP FOR THE PREVENTION AND SYMPTOMATIC RELIEF OF ALLERGIC MANIFESTATIONS, SUCH AS: SEASONAL ALLERGIC RHINITIS, PERENNIAL ALLERGIC RHINITIS AND CHRONIC IDIOPATHIC URTICARIA NULL VIMPEX (LAO) CO.,LTD BEXIMCO PHARMACEUTICALS LIMITED BANGLADESH CERTIFICATE RELEASED 10 I 5634/23 17-OCT-2023 16-OCT-2026 View
2815 AXODIN 60 TABLET FEXOFENADINE HYDROCHLORIDE PH.EUR 60 MG TABLET ALU-PVDC STRIP FOR THE RELIEF OF THE SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN 2 YEARS OF AGE AND OLDER, TREATMENT OF UNCOMPLICATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA IN ADULTS AND CHILDREN 6 MONTHS OF AGE AND OLDER, NULL VIMPEX (LAO) CO.,LTD BEXIMCO PHARMACEUTICALS LIMITED BANGLADESH CERTIFICATE RELEASED 10 I 5635/23 17-OCT-2023 16-OCT-2026 View
2816 AZITHROCIN 500 TABLET AZITHROMYCIN DIHYDRATE 524 MG EQ.TO AZITHROMYCIN USP 500 MG TABLET ALU-ALU STRIP FOR THE FOLLOWING BACTERIAL INFECTIONS INDUCED BY NICRO-ORGANISMS SUSCEPTIBLE TO AZITHROMYCIN: ACUTE BACTERIAL SINUSITIS (ADEQUATELY DIAGNOSED), ACUTE BACTERIAL OTITIS MEDIA (ADEQUATELY DIAGNOSED), PHARYNGITIS AND TONSILLITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, MILD TO MODERATELY SEVERE COMMUNITY ACQUIRED PNEUMONIA, INFECTION OF THE SKIN AND SOFT TISSUE, UNCOMPLICATED CHLAMYDIA TRACHOMATIS URETHRITIS AND CERVICITIS NULL VIMPEX (LAO) CO.,LTD BEXIMCO PHARMACEUTICALS LIMITED BANGLADESH CERTIFICATE RELEASED 10 I 5636/23 17-OCT-2023 16-OCT-2026 View
2817 BACTIGEN EYE/EAR DROPS GENTAMICIN SULFATE BP 0.3 % W/V EYE/EAR DROPS VIAL FOR THE TREATMENT OF SUPERFICIAL EYE AND EAR INFECTION CAUSED BY ORGANISM SENSITIVITY TO GENTAMICIN. PROPHYLAXIS AGAINST INFECTION IN TRAUMA OF EYE OR EAR NULL VIMPEX (LAO) CO.,LTD FDC LIMITED INDIA CERTIFICATE RELEASED 06 I 5771/24 27-Jun-2024 26-Jun-2027 View
2818 BETADERM CREAM BETAMETHASONE (AS VALERATE BP) 0.1 % W/W CREAM TUBE TO PREVENT INFECTION AND IMMEDIATE RELIEF IN SURGICAL INCISIONS, ACCIDENTAL CUTS, BURNS, SCRATCHES, ABRASIONS AND OTHER PRIMARY INFECTED DERMATOSIS LIKE CELLULITIS, FOLLICULITIS, FURUNCULOSIS, CARBUNCLE AND IMPETIGO NULL VIMPEX (LAO) CO.,LTD ATCO LABORATORIES LIMITED PAKISTAN CERTIFICATE RELEASED 12 I 5353/22 30-DEC-2022 29-DEC-2025 View
2819 BETADERM-N CREAM BETAMETHASONE (AS VALERATE BP) 0.1 % W/W, NEOMYCIN SULPHATE 0.5 % W/W CREAM TUBE TO PREVENT INFECTION AND IMMEDIATE RELIEF IN SURGICAL INCISIONS, ACCIDENTAL CUTS, BURNS, SCRATCHES, ABRASIONS AND OTHER PRIMARY INFECTED DERMATOSIS LIKE CELLULITIS, FOLLICULITIS, FURUNCULOSIS, CARBUNCLE AND IMPETIGO NULL VIMPEX (LAO) CO.,LTD ATCO LABORATORIES LIMITED PAKISTAN CERTIFICATE RELEASED 12 I 5354/22 30-DEC-2022 29-DEC-2025 View
2820 BEXITROL F 25/125 HFA SALMETEROL XINAFOATE BP 36.25 MCG EQ . TO SALMETEROL 25 MCG ,FLUTICASONE PROPIONATE BP 125 MCG AEROSOL BOTTLE REGULAR TREATMENT OF ASTHMA WHERE USE OF A COMBINATION PRODUCT( LONG-ACTING BETA 2-AGONIST AND INHALED CORTICOSTEROID) IS APPROPRIATE NULL VIMPEX (LAO) CO.,LTD BEXIMCO PHARMACEUTICALS LTD BANGLADESH CERTIFICATE RELEASED 06 I 4733/19 08-JAN-2024 07-JAN-2027 View